151 related articles for article (PubMed ID: 38436544)
1. RPL35A drives ovarian cancer progression by promoting the binding of YY1 to CTCF promoter.
Wu H; Xia L; Sun L; Li D; Liu X; Song H; Sheng J; Wang K; Feng Q
J Cell Mol Med; 2024 Mar; 28(6):e18115. PubMed ID: 38436544
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of human DUSP4 gene by cancer-related transcription factors.
Varela T; Conceição N; Laizé V; Cancela ML
J Cell Biochem; 2021 Oct; 122(10):1556-1566. PubMed ID: 34254709
[TBL] [Abstract][Full Text] [Related]
3. YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis.
You Q; Yao Y; Wu J; Cheng C; Li Y; Yuan H
Biomed Pharmacother; 2020 Sep; 129():110339. PubMed ID: 32563147
[TBL] [Abstract][Full Text] [Related]
4. RPL35A promotes the progression of cholangiocarcinoma by mediating HSPA8 ubiquitination.
Zhang C; Wang Y; Wu G; Sun N; Bai H; Li X; Han S; Zhou H; Qi R; Zhang J
Biol Direct; 2024 Feb; 19(1):16. PubMed ID: 38395908
[TBL] [Abstract][Full Text] [Related]
5. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
6. Co-binding by YY1 identifies the transcriptionally active, highly conserved set of CTCF-bound regions in primate genomes.
Schwalie PC; Ward MC; Cain CE; Faure AJ; Gilad Y; Odom DT; Flicek P
Genome Biol; 2013 Dec; 14(12):R148. PubMed ID: 24380390
[TBL] [Abstract][Full Text] [Related]
7. MiR-381 inhibits epithelial ovarian cancer malignancy via YY1 suppression.
Xia B; Li H; Yang S; Liu T; Lou G
Tumour Biol; 2016 Jul; 37(7):9157-67. PubMed ID: 26768613
[TBL] [Abstract][Full Text] [Related]
8. Yin yang 1 modulates taxane response in epithelial ovarian cancer.
Matsumura N; Huang Z; Baba T; Lee PS; Barnett JC; Mori S; Chang JT; Kuo WL; Gusberg AH; Whitaker RS; Gray JW; Fujii S; Berchuck A; Murphy SK
Mol Cancer Res; 2009 Feb; 7(2):210-20. PubMed ID: 19208743
[TBL] [Abstract][Full Text] [Related]
9. Cloning, sequencing and expression of a cDNA encoding the mouse L35a ribosomal protein during differentiation of murine erythroleukemia (MEL) cells.
Pappas IS; Vizirianakis IS; Tsiftsoglou AS
Cell Biol Int; 2001; 25(7):629-34. PubMed ID: 11448102
[TBL] [Abstract][Full Text] [Related]
10. Transcription Factor YY1 Modulates Lung Cancer Progression by Activating lncRNA-PVT1.
Huang T; Wang G; Yang L; Peng B; Wen Y; Ding G; Wang Z
DNA Cell Biol; 2017 Nov; 36(11):947-958. PubMed ID: 28972861
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia.
Farrar JE; Nater M; Caywood E; McDevitt MA; Kowalski J; Takemoto CM; Talbot CC; Meltzer P; Esposito D; Beggs AH; Schneider HE; Grabowska A; Ball SE; Niewiadomska E; Sieff CA; Vlachos A; Atsidaftos E; Ellis SR; Lipton JM; Gazda HT; Arceci RJ
Blood; 2008 Sep; 112(5):1582-92. PubMed ID: 18535205
[TBL] [Abstract][Full Text] [Related]
12. miR-5590-3p-YY1 feedback loop promotes the proliferation and migration of triple-negative breast cancer cells.
Liang F; Fu X; Wang L
J Cell Biochem; 2019 Oct; 120(10):18415-18424. PubMed ID: 31190375
[TBL] [Abstract][Full Text] [Related]
13. YY1 and CTCF orchestrate a 3D chromatin looping switch during early neural lineage commitment.
Beagan JA; Duong MT; Titus KR; Zhou L; Cao Z; Ma J; Lachanski CV; Gillis DR; Phillips-Cremins JE
Genome Res; 2017 Jul; 27(7):1139-1152. PubMed ID: 28536180
[TBL] [Abstract][Full Text] [Related]
14. CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway.
Yang J; Fan L; Liao X; Cui G; Hu H
Bioengineered; 2021 Dec; 12(2):9377-9389. PubMed ID: 34818994
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression.
Lin CC; Kuo IY; Wu LT; Kuan WH; Liao SY; Jen J; Yang YE; Tang CW; Chen YR; Wang YC
Theranostics; 2020; 10(22):10001-10015. PubMed ID: 32929330
[TBL] [Abstract][Full Text] [Related]
16. CTCF regulates the FoxO signaling pathway to affect the progression of prostate cancer.
Shan Z; Li Y; Yu S; Wu J; Zhang C; Ma Y; Zhuang G; Wang J; Gao Z; Liu D
J Cell Mol Med; 2019 May; 23(5):3130-3139. PubMed ID: 30873749
[TBL] [Abstract][Full Text] [Related]
17. MiR-98-3p regulates ovarian granulosa cell proliferation and apoptosis in polycystic ovary syndrome by targeting YY1.
Hu M; Gao T; Du Y
Med Mol Morphol; 2022 Mar; 55(1):47-59. PubMed ID: 34796378
[TBL] [Abstract][Full Text] [Related]
18. YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor.
Dong S; Ma X; Wang Z; Han B; Zou H; Wu Z; Zang Y; Zhuang L
Oncotarget; 2017 Jun; 8(25):40583-40593. PubMed ID: 28489564
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of miR-146a by YY1 depletion correlates with delayed progression of prostate cancer.
Huang Y; Tao T; Liu C; Guan H; Zhang G; Ling Z; Zhang L; Lu K; Chen S; Xu B; Chen M
Int J Oncol; 2017 Feb; 50(2):421-431. PubMed ID: 28101571
[TBL] [Abstract][Full Text] [Related]
20. YY1 associates with the macrosatellite DXZ4 on the inactive X chromosome and binds with CTCF to a hypomethylated form in some male carcinomas.
Moseley SC; Rizkallah R; Tremblay DC; Anderson BR; Hurt MM; Chadwick BP
Nucleic Acids Res; 2012 Feb; 40(4):1596-608. PubMed ID: 22064860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
